Back to results
US 9,040,048 B2Granted
Antibody molecules having specificity for human OX40
AssigneeUcb Biopharma Sprl
InventorsRalph Adams, Pallavi Bhatta, Sam Philip Heywood, David Paul Humphreys
Life of this patent
Estimating the term…
Abstract
The invention relates to antibody molecules having specificity for antigenic determinants of human OX40, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
Claims11
A bispecific antibody fusion protein which binds human OX40 and human serum albumin comprising:
- a heavy chain comprising, in sequence from the N-terminal, a first heavy chain variable domain (VH1), a CH1 domain and a second heavy chain variable domain (VH2),
- a light chain comprising, in sequence from the N-terminal, a first light chain variable domain (VL1), a CL domain and a second light chain variable domain (VL2),
- wherein said heavy and light chains are aligned such that VH1 and VL1 form a first antigen binding site and VH2 and VL2 form a second antigen binding site,
- wherein the antigen bound by the first antigen binding site is human OX40 and the antigen bound by the second antigen binding site is human serum albumin,
- wherein the first variable domain of the heavy chain (VH1)comprises the sequence given in SEQ ID NO:1 for CDR-H1, the sequence given in SEQ ID NO:2 for CDR-H2 and the sequence given in SEQ ID NO:3 for CDR-H3 and the first variable domain of the light chain (VL1comprises the sequence given in SEQ ID NO:4 for CDR-L1, the sequence given in SEQ ID NO:5 for CDR-L2 and the sequence given in SEQ ID NO:6 for CDR-L3,
- wherein the second heavy chain variable domain (VH2)has the sequence given in SEQ ID NO:11 and the second light chain variable domain (VL2)has the sequence given in SEQ ID NO:12 and
- the second heavy chain variable domain (VH2)and second light chain variable domain (VL2) are linked by a disulphide bond.
4 more elements
A bispecific antibody fusion protein which binds human OX40 and human serum albumin, having a heavy chain comprising the sequence given in SEQ ID NO:15 and a light chain comprising the sequence given in SEQ ID NO:16.
Dependencies are inferred from the claim text.